CD169 + Macrophage‐Targeted Immunomodulator to Restore Phagocytic Function and Enhance Antigen Presentation for Lymphatic Metastasis Eradication
Advanced Science · 2026
DOI: 10.1002/advs.202514386 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Xiayun Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, the Sc…. Hauptthemen laut MEDLINE: Antigen Presentation, Macrophages, Sialic Acid Binding Ig-like Lectin 1, Lymphatic Metastasis. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Open Project of State Key Laboratory of Respiratory Disease.
Abstract (Originalsprache)
Lymphatic metastasis is a major cause of tumor treatment failure, with the immunosuppressive status of lymphatic macrophages significantly impairing antitumor immunity. In this study, it is found that CD169 + macrophages in lymphatic metastasis exhibit impaired phagocytic activity and diminished antigen‐presenting capacity, which correlates with suppressed antitumor immune responses. Based on these discoveries, a CD169 + macrophage‐targeted immunomodulator (designated as G‐LNP@S‐D) is fabricated to restore phagocytic function and enhance antigen presentation for lymphatic metastasis eradication. G‐LNP@S‐D consists of GM1‐functionalized liposomes co‐encapsulating the SHP2 inhibitor SHP099 and the STING agonist DMXAA, enabling sequential lymph node‐ and CD169 + macrophage‐specific drug delivery. Mechanistically, G‐LNP@S‐D not only restores the phagocytic capacity of CD169 + macrophages to eliminate tumor cells but also activates the STING pathway to enhance antigen presentation and subsequent T cell priming. Immunological profiling confirms that G‐LNP@S‐D treatment promotes the infiltration of CD4 + and CD8 + T cells in both TDLNs and primary tumors. Importantly, G‐LNP@S‐D exerts systemic immunomodulatory effects for directly eradicating lymphatic metastases. This study elucidates a sophisticated lymph node immune‐modulation strategy and provides a promising therapeutic approach to treat lymphatic metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, the School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzh…
- Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics, Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, P. R. China.
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore.
- Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
- Theranostics Center of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 138667, Singapore.
- Department of Chemical and Biomolecular Engineering, College of Design and Engineering, National University of Singapore, Singapore, 117575, Singapore.
ORCID-Profile: Xiaoyuan Chen
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Open Project of State Key Laboratory of Respiratory Disease
- National University of Singapore
- National Medical Research Council
- National Research Foundation
- National Key Research and Development Program of China
Zitieren
APA
Chen, X., Lu, L., Liu, Y., Liang, Z., Li, J., Shao, Z., Tang, Y., Zou, J., Li, S., & Chen, X. (2026). CD169 + Macrophage‐Targeted Immunomodulator to Restore Phagocytic Function and Enhance Antigen Presentation for Lymphatic Metastasis Eradication. Advanced Science. https://doi.org/10.1002/advs.202514386
Vancouver
Chen X, Lu L, Liu Y, Liang Z, Li J, Shao Z, et al. CD169 + Macrophage‐Targeted Immunomodulator to Restore Phagocytic Function and Enhance Antigen Presentation for Lymphatic Metastasis Eradication. Advanced Science. 2026. doi:10.1002/advs.202514386
BibTeX
@article{Chen2026,
author = {Chen, Xiayun and Lu, Lichong and Liu, Yibin and Liang, Ziqi and Li, Jianqiao and Shao, Zhouchuan and Tang, Youzhi and Zou, Jianhua and Li, Shiying and Chen, Xiaoyuan},
title = {CD169 + Macrophage‐Targeted Immunomodulator to Restore Phagocytic Function and Enhance Antigen Presentation for Lymphatic Metastasis Eradication},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202514386}
}
EUVIMED